Opdyta
Nivolumab
- Strength
- 100mg/40mg
- Manufacturer
- BMS Pharma
- Availability
- Available to source
Nivolumab 100mg/40mg — Injection, 1's Vial
Need assistance?
Our multilingual healthcare support team can help with availability, shipping and ordering.
Chat on WhatsApp
Scan for WeChat
About this medicine
Originator: OPDIVO by Bristol-Myers Squibb · Manufacturer: BMS Pharma. Indication & Dosage: Opdyta (Nivolumab), generic OPDIVO is a prescription medicine used to treat lung cancer, head and neck squamous cell cancer, skin cancer (called melanoma), kidney cancer, classical Hodgkin lymphoma (a type of blood cancer), urothelial carcinoma (bladder cancer), liver cancer, colorectal cancer. Opdyta manufactured by BMS India Pvt. Ltd. in India. Nivolumab has to inject slowly into a vein over 30 to 60 minutes, usually once every 2 to 4 weeks. Side Effects: The most common adverse reactions of Nivolumab are: Diarrhea , fever, fatigue , shortness of breath, decreased appetite, cough, nausea , constipation, rash, stomach/ abdominal pain, mouth/ throat sores, vomiting , unusual weakness, headache , pain in muscles, bones, and joints . The above information comes from the Internet. Please consult with doctor for medical advice.
Indications
This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.
